Skip to main content
Fig. 3 | Biomarker Research

Fig. 3

From: Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer

Fig. 3

AR-FL and AR-Vs expression levels during disease progression. Shown are detection signals for AR-FL and AR-Vs in primary tumor tissue samples (A, n = 20) and metastatic tumor tissue samples (B, n = 10). C Copy number determination of AR-FL and AR-Vs in primary tumor tissue samples (PT) and metastatic tumor tissue samples (M) (** represents p < 0.01)

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us